Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Graves Disease

In brief

The purpose of this study is to evaluate the efficacy and safety of BHV-1300 in adult participants with Graves' disease who are actively hyperthyroid

Key facts

Study ID
NCT07661056
Run by
Biohaven Therapeutics Ltd.
People needed
300
Starts
2026-06-26
Expected to finish
2028-02-01
Last updated by the study team
2026-08-07

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.